Comment on an open trial of lurasidone as an acute and maintenance adjunctive treatment for outpatients with treatment-resistant bipolar disorder

Ian Ross McGrane; Matej Stuhec

doi:10.1097/JCP.0000000000000562

Comment on an open trial of lurasidone as an acute and maintenance adjunctive treatment for outpatients with treatment-resistant bipolar disorder

Ian Ross McGrane
, Matej Stuhec

Pharmacy Practice

University of Ljubljana

Research output: Contribution to journal › Letter › peer-review

3 Scopus citations

Original language	English
Pages (from-to)	520-521
Number of pages	2
Journal	Journal of Clinical Psychopharmacology
Volume	36
Issue number	5
DOIs	https://doi.org/10.1097/JCP.0000000000000562
State	Published - Oct 1 2016

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Access to Document

10.1097/JCP.0000000000000562

Cite this

@article{81b8e0f007c94fed8d3e584df118429d,

title = "Comment on an open trial of lurasidone as an acute and maintenance adjunctive treatment for outpatients with treatment-resistant bipolar disorder",

author = "McGrane, \{Ian Ross\} and Matej Stuhec",

year = "2016",

month = oct,

day = "1",

doi = "10.1097/JCP.0000000000000562",

language = "English",

volume = "36",

pages = "520--521",

journal = "Journal of Clinical Psychopharmacology",

issn = "0271-0749",

publisher = "Lippincott Williams and Wilkins",

number = "5",

}

TY - JOUR

T1 - Comment on an open trial of lurasidone as an acute and maintenance adjunctive treatment for outpatients with treatment-resistant bipolar disorder

AU - McGrane, Ian Ross

AU - Stuhec, Matej

PY - 2016/10/1

Y1 - 2016/10/1

UR - https://www.scopus.com/pages/publications/84981715664

U2 - 10.1097/JCP.0000000000000562

DO - 10.1097/JCP.0000000000000562

M3 - Letter

C2 - 27518474

AN - SCOPUS:84981715664

SN - 0271-0749

VL - 36

SP - 520

EP - 521

JO - Journal of Clinical Psychopharmacology

JF - Journal of Clinical Psychopharmacology

IS - 5

ER -

Comment on an open trial of lurasidone as an acute and maintenance adjunctive treatment for outpatients with treatment-resistant bipolar disorder

UN SDGs

Access to Document

Other files and links

Cite this